Stockscreener 앱 받기
4.62
0.65%
0.03
시간 외 거래:
4.36
-0.26
-5.63%
전일 마감가:
$4.59
열려 있는:
$4.62
하루 거래량:
32,862
Relative Volume:
2.90
시가총액:
$1.83M
수익:
$502.00K
순이익/손실:
$-8.86M
주가수익비율:
-0.8148
EPS:
-5.67
순현금흐름:
$-10.71M
1주 성능:
+2.91%
1개월 성능:
-21.03%
6개월 성능:
-43.59%
1년 성능:
-89.27%
1일 변동 폭
$4.3016
$4.7498
1주일 범위
$3.318
$5.31
52주 변동 폭
$3.318
$48.15
Helius Medical Technologies Inc Stock (HSDT) Company Profile
명칭
Helius Medical Technologies Inc
전화
215-944-6100
주소
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
HSDT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
4.62 | 1.83M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-24 | 개시 | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc 주식(HSDT)의 최신 뉴스
Newtown-Based Helius Medical Technologies Issues Reverse Stock Split - BUCKSCO.Today
Helius Medical Technologies announces 1-for-15 reverse stock split - MSN
HELIUS MEDICAL TECHNOLOGIES, INC. SEC 10-Q Report - TradingView
Helius Medical Technologies initiates 1-for-15 reverse stock split to meet Nasdaq requirements - The Business Journals
Helius Medical (HSDT) Initiates 1-for-15 Reverse Stock Split | H - GuruFocus
Helius Announces 1-for-15 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
HSDT stock touches 52-week low at $0.26 amid sharp annual decline - Investing.com
Helius Medical Technologies Announces Reverse Stock Split - marketscreener.com
Helius Medical announces 1-for-15 reverse stock split By Investing.com - Investing.com India
Helius Medical announces 1-for-15 reverse stock split - Investing.com
Helius Medical's 1:15 Reverse Split Aims to Meet Nasdaq Requirements: What Shareholders Must Know - Stock Titan
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - The Globe and Mail
Helius Medical secures $1.3M in private placement - Investing.com Australia
Helius Medical secures $1.3M in private placement By Investing.com - Investing.com South Africa
HELIUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm - ACCESS Newswire
Helius Medical Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - Quantisnow
HSDT stock plunges to 52-week low of $0.37 amid steep decline - Investing.com
Virtu Financial LLC Purchases New Shares in Helius Medical Technologies, Inc. (NASDAQ:HSDT) - Defense World
Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation - MSN
Helius Medical Creates Brain-Computer Interface Subsidiary - Medical Product Outsourcing
SEC Form 424B5 filed by Helius Medical Technologies Inc. - Quantisnow
Helius Medical Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Helius Medical Technologies Inc. (HSDT) reports earnings - Quartz
Chronic Traumatic Encephalopathy Pipeline 2025: MOA, ROA, - openPR.com
Helius Medical Technologies Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Chronic Traumatic Encephalopathy Treatment Market Size in 7MM - openPR.com
Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study - MSN
Helius Medical Technologies (HSDT) Expected to Announce Quarterly Earnings on Wednesday - The AM Reporter
Helius Medical Secures First Insurance Reimbursement for PoNS Device - MSN
Helius joins BCI landscape with new subsidiary - Yahoo
Helius Medical launches AI-driven BCI subsidiary - Investing.com Australia
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ('BCI”) Technology Private Subsidiary - The Manila Times
Helius Medical launches AI-driven BCI subsidiary By Investing.com - Investing.com UK
Helius Medical Technologies, Inc. Announces the - GlobeNewswire
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer ... - Bluefield Daily Telegraph
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary - TradingView
Helius Medical's New AI Brain Interface Venture Aims to Transform Neurorehabilitation Without Surgery - StockTitan
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times
Helius Medical Technologies, Inc. Announces First - GlobeNewswire
Helius Medical announces first reimbursement for PoNS Device - TipRanks
Major Breakthrough: Anthem BCBS Approves $15,420 Payment for Helius Medical's PoNS Device - StockTitan
Helius Medical Technologies, Inc. (NASDAQ: HSDT) Featured in Coverage of the 37th Annual ROTH Conference - Financial Content
Helius Medical Tech Stock Price, Quotes and Forecasts | NASDAQ:HSDT - Benzinga
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program - MSN
Analyzing Helius Medical Technologies (NASDAQ:HSDT) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) - The AM Reporter
Neurology Devices Market Detailed In New Research Report 2025 | - openPR
Research Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita Therapeutics - ACCESS Newswire
Helius Medical faces Nasdaq delisting over bid price By Investing.com - Investing.com Canada
Helius Medical Technologies (NASDAQ:HSDT) Shares Down 5.8% – What’s Next? - Armenian Reporter
Helius Medical Technologies Inc (HSDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.62%
0.20%
자본화:
|
볼륨(24시간):